
Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Healthcare venture growth equity firm investing in later-stage healthcare companies alongside management teams

Healthcare is the only thing Questa Capital invests in. The firm calls itself a venture growth equity investor for healthcare companies that are already breaking out, with offices in Washington, DC and San Francisco, and it sets out to find business models that improve lives while delivering better and more efficient care.
Its partners say they have been active in healthcare investing since 1996. Earlier in their careers they served at New Enterprise Associates and Parthenon Capital, and the firm reports that together they have sat on the boards of more than 60 growth-stage companies, guided 34 of them to successful exits, and accumulated more than 75 combined years of experience building growth businesses. It describes its mission as generating strong returns for both its investors and its management teams by backing healthcare leaders who are building the next generation of growth companies, and says its role is to assist, coach, advise and champion them.
The firm focuses on later-stage companies. It can take a majority or a minority position, and it describes its capital as meant to speed up a strategic growth plan or, in some cases, to give founders or early shareholders partial liquidity. Its partners have committed substantial personal capital to the fund and expect management teams to show a similar commitment. It describes a research-driven, thematic approach, which it calls the prepared mind, so that the team can act quickly when an opportunity appears.
Questa describes itself as a fundamental investor that steers clear of situations with large binary risk. It says it shies away from companies that depend on a single dominant customer, face a vulnerable reimbursement position or rest on unproven technology, and it prefers capital-efficient models over those with open-ended funding needs. It expects technology to improve efficiency in every business it backs: as an optimizer of care delivery in service companies, as the basis for new offerings in digital health, and as protected intellectual property in medical device firms. It also sees patients behaving more like consumers, and so favors companies that improve care and quality of life at lower cost to the system.
The portfolio highlighted today includes a maker of connected portable defibrillators aimed at raising survival from sudden cardiac arrest, a kidney stone treatment company, a provider of neurological therapies for children with autism and other developmental differences, a maker of AI-assisted stethoscopes, a marketplace connecting payers and specialty pharmacies, and a developer of bio-integrative orthopedic implants.
Questa Capital is a venture growth equity firm that invests only in healthcare. It targets later-stage companies with business models that improve care quality and efficiency, and backs them on a majority or minority basis.
Entrepreneurial chief executives and management teams in healthcare. Partners have committed personal money to the fund and expect a similar commitment from management.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Questa Capital.
Similar listings buyers compare against this one.

Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Startup accelerator and early-stage investor running intensive batches for new technology founders

Venture capital firm backing pre-seed deep technology startups in health and planetary sustainability

Silicon Valley venture capital firm investing from seed to growth stage across technology sectors

Global venture capital firm and accelerator backing early-stage technology founders, formerly called 500 Startups

Venture firm investing in life sciences and techbio startups working to improve patient care

Student-run evergreen venture fund at the University of Michigan investing in technology and life sciences startups

Corporate venture arm of the Volvo Group investing in startups that change transport and logistics
Everything here links back to the same verified catalogue. Pick your next stop.